Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia

V Di Lazzaro, R Bella, A Benussi, M Bologna… - Clinical …, 2021 - Elsevier
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …

The role of noradrenaline in cognition and cognitive disorders

N Holland, TW Robbins, JB Rowe - Brain, 2021 - academic.oup.com
Many aspects of cognition and behaviour are regulated by noradrenergic projections to the
forebrain originating from the locus coeruleus, acting through alpha and beta …

α-Synucleinopathy phenotypes

H McCann, CH Stevens, H Cartwright… - Parkinsonism & related …, 2014 - Elsevier
Summary α-Synucleinopathies are neurodegenerative diseases characterised by the
abnormal accumulation of α-synuclein aggregates in neurons, nerve fibres or glial cells …

Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the …

A Fanciulli, J Jordan, I Biaggioni… - Clinical Autonomic …, 2018 - Springer
Purpose Patients suffering from cardiovascular autonomic failure often develop neurogenic
supine hypertension (nSH), ie, high blood pressure (BP) in the supine position, which falls in …

Neuropathology underlying clinical variability in patients with synucleinopathies

GM Halliday, JL Holton, T Revesz, DW Dickson - Acta neuropathologica, 2011 - Springer
Abnormal aggregates of the synaptic protein, α-synuclein, are the dominant pathology in
syndromes known as the synucleinopathies. The cellular aggregation of the protein occurs …

Improving diagnostic accuracy of multiple system atrophy: a clinicopathological study

Y Miki, SC Foti, YT Asi, E Tsushima, N Quinn, H Ling… - Brain, 2019 - academic.oup.com
Clinical diagnosis of multiple system atrophy is challenging and many patients with Lewy
body disease (ie Parkinson's disease or dementia with Lewy bodies) or progressive …

Multiple system atrophy: an oligodendroglioneural synucleinopathy

KA Jellinger - Journal of Alzheimer's Disease, 2018 - content.iospress.com
Multiple system atrophy (MSA) is an orphan, fatal, adult-onset neurodegenerative disorder of
uncertain etiology that is clinically characterized by various combinations of parkinsonism …

Davunetide in patients with progressive supranuclear palsy: a randomised, double-blind, placebo-controlled phase 2/3 trial

AL Boxer, AE Lang, M Grossman, DS Knopman… - The Lancet …, 2014 - thelancet.com
Background In preclinical studies, davunetide promoted microtubule stability and reduced
tau phosphorylation. Because progressive supranuclear palsy (PSP) is linked to tau …

Diagnosis of multiple system atrophy

JA Palma, L Norcliffe-Kaufmann, H Kaufmann - Autonomic Neuroscience, 2018 - Elsevier
Multiple system atrophy (MSA) may be difficult to distinguish clinically from other disorders,
particularly in the early stages of the disease. An autonomic-only presentation can be …

The neuropathology, pathophysiology and genetics of multiple system atrophy

Z Ahmed, YT Asi, A Sailer, AJ Lees… - Neuropathology and …, 2012 - Wiley Online Library
Z. Ahmed, YT Asi, A. Sailer, AJ Lees, H. Houlden, T. Revesz and JL Holton (2012)
Neuropathology and Applied Neurobiology38, 4–24 The neuropathology, pathophysiology …